Global Prostate Specific Antigen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prostate Specific Antigen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Prostate Specific Antigen report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prostate Specific Antigen market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prostate Cancer and Metastatic Hormone Refractory Prostate Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prostate Specific Antigen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prostate Specific Antigen key manufacturers include Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc. and OncBioMune Pharmaceuticals Inc., etc. Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S are top 3 players and held % sales share in total in 2022.
Prostate Specific Antigen can be divided into G-115, INO-5150, ADXS-PSA and AEZS-120, etc. G-115 is the mainstream product in the market, accounting for % sales share globally in 2022.
Prostate Specific Antigen is widely used in various fields, such as Prostate Cancer, Metastatic Hormone Refractory Prostate Cancer and Others,, etc. Prostate Cancer provides greatest supports to the Prostate Specific Antigen industry development. In 2022, global % sales of Prostate Specific Antigen went into Prostate Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostate Specific Antigen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
Segment by Type
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prostate Specific Antigen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prostate Specific Antigen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prostate Specific Antigen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prostate Specific Antigen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prostate Specific Antigen introduction, etc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prostate Specific Antigen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Prostate Specific Antigen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prostate Specific Antigen key manufacturers include Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc. and OncBioMune Pharmaceuticals Inc., etc. Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S are top 3 players and held % sales share in total in 2022.
Prostate Specific Antigen can be divided into G-115, INO-5150, ADXS-PSA and AEZS-120, etc. G-115 is the mainstream product in the market, accounting for % sales share globally in 2022.
Prostate Specific Antigen is widely used in various fields, such as Prostate Cancer, Metastatic Hormone Refractory Prostate Cancer and Others,, etc. Prostate Cancer provides greatest supports to the Prostate Specific Antigen industry development. In 2022, global % sales of Prostate Specific Antigen went into Prostate Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostate Specific Antigen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
Segment by Type
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
Segment by Application
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prostate Specific Antigen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prostate Specific Antigen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prostate Specific Antigen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prostate Specific Antigen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prostate Specific Antigen introduction, etc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prostate Specific Antigen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.